Core Viewpoint - The rising incidence of thyroid cancer globally has prompted the establishment of a "Thyroid Cancer Prevention and Treatment Day" to enhance awareness and promote comprehensive management of the disease [1] Group 1: Disease Awareness and Management - Thyroid cancer is the most common malignant tumor in the head and neck, often misperceived as a "lazy cancer" due to its slow progression and high early survival rates [1] - There is a widespread misconception among the public regarding the severity of thyroid cancer, leading to insufficient postoperative follow-up and long-term management [1] - The incidence of thyroid cancer in China is rapidly increasing, necessitating a shift from single treatment approaches to comprehensive management throughout the disease cycle [1] Group 2: Expert Insights on Treatment - Professor Tian Wen emphasizes that the term "lazy cancer" is misleading, as certain types of thyroid cancer can be highly malignant and life-threatening [2] - Patients should not rely solely on the size or growth rate of nodules to assess malignancy; proper diagnosis requires preoperative puncture or postoperative pathological results [2] - Dynamic assessment and standardized follow-up are crucial, as many patients neglect postoperative management, increasing the risk of metastasis or recurrence [2] Group 3: Postoperative Follow-Up Recommendations - Key to postoperative dynamic assessment is raising the patient's thyroid-stimulating hormone levels to the target range for effective monitoring [3] - Follow-up should begin one month post-surgery to evaluate wound recovery and medication status, with ultrasound and thyroid function tests at three months [3] - Initially, follow-ups should be frequent in the first six months, gradually extending to three months, six months, or even annually, based on pathological stratification and individual circumstances [3]

Core Insights - The incidence of thyroid cancer in China is rapidly increasing, with 466,100 new cases reported in 2024, making it the third most common cancer, particularly affecting younger populations [1][4] - There is a prevalent misconception among the public that thyroid cancer is a "lazy cancer," leading to insufficient follow-up and long-term management [1][2] - Clinical experts emphasize the need to break this misconception and raise awareness about the potential dangers and recurrence risks associated with thyroid cancer [1][3] Group 1: Incidence and Demographics - Thyroid cancer has become the most common cancer among young people aged 15-29, with a significant increase in cases among women, whose incidence rate is 49.4 per 100,000 [1][5] - Since 2000, the annual growth rate of thyroid cancer incidence among women has been approximately 20%, making it one of the most common cancers in Chinese women [5] Group 2: Misconceptions and Risks - The term "lazy cancer" is deemed unscientific and misleading, as there are highly malignant types of thyroid cancer that can progress rapidly and pose life-threatening risks [1][2] - The overall survival rate for thyroid cancer in China is 92.9%, but the recurrence rate can reach 20% after 10 years, with high-risk groups exceeding 30% [5][6] Group 3: Management and Follow-Up - Post-surgery management is crucial, with a need for dynamic assessment and standardized follow-up to minimize recurrence and metastasis risks [6][8] - Patients should undergo stratified assessments based on pathology, tumor size, and lymph node involvement to determine follow-up frequency and treatment strategies [8][10] Group 4: Treatment Protocols - High-risk patients may require additional treatments such as iodine-131 therapy, while low-risk patients still need careful monitoring due to potential changes in risk status [8][9] - The use of recombinant human thyroid-stimulating hormone (rh-TSH) for dynamic assessment is recommended to improve patient compliance and long-term survival rates [9][10] Group 5: Lifestyle and Awareness - Patients are encouraged to maintain a balanced diet, avoid excessive iodine intake, and manage stress to reduce recurrence risks [10] - Establishing a Thyroid Cancer Prevention and Treatment Day is suggested to enhance public awareness and shift management approaches from treatment-focused to comprehensive care [10]

Core Insights - The incidence of thyroid cancer in China is rapidly increasing, with 466,100 new cases reported in 2024, making it the third most common malignant tumor, particularly affecting younger populations [1][3] - There is a prevalent misconception among the public that thyroid cancer is a "lazy cancer," leading to insufficient awareness regarding postoperative follow-up and long-term management [1][4] - Despite a high survival rate of 92.9% over five years, the recurrence rate can reach 20% post-surgery, necessitating a shift towards comprehensive management strategies [4][6] Group 1: Incidence and Demographics - In the 15-29 age group, thyroid cancer has the highest number of new cases among all cancers [1] - The female incidence rate of thyroid cancer is approximately 49.4 per 100,000, with a 20% annual increase since 2000, making it one of the most common cancers among women in China [3][4] Group 2: Misconceptions and Risks - The term "lazy cancer" is deemed unscientific, as it overlooks the existence of highly malignant types of thyroid cancer that can progress rapidly and pose life-threatening risks [1][3] - The misconception leads to delays in diagnosis and treatment, emphasizing the need for public education on the seriousness of thyroid cancer [2][4] Group 3: Management and Follow-Up - Postoperative management is crucial, with a need for dynamic assessment based on risk stratification (high, medium, low) to determine follow-up frequency and treatment [6][8] - The use of recombinant human thyroid-stimulating hormone (rh-TSH) for dynamic evaluation is recommended to improve patient compliance and long-term survival rates [7][8] Group 4: Treatment and Lifestyle Recommendations - Patients are advised against self-adjusting medication dosages and should follow medical guidance for long-term thyroid hormone suppression therapy [8] - A balanced diet and lifestyle, including regular exercise and stress management, are encouraged to reduce recurrence risks [8]

Core Insights - The incidence of thyroid cancer in China is rapidly increasing, with 466,100 new cases reported in 2024, making it the third most common cancer, particularly affecting younger populations [1][3] - There is a prevalent misconception among the public that thyroid cancer is a "lazy cancer," leading to insufficient follow-up and long-term management [1][3] - Clinical experts emphasize the need to break this misconception and raise awareness about the potential dangers and recurrence risks associated with thyroid cancer [1][3] Incidence and Demographics - In the 15-29 age group, thyroid cancer has the highest number of new cases among all cancers [1] - The 2025 Beijing Health Report indicates that thyroid cancer accounts for 48.8% of all cancer diagnoses during health screenings [1] - The female incidence rate of thyroid cancer is 49.4 per 100,000, with a 20% annual increase since 2000, making it one of the most common cancers among women in China [3] Mortality and Survival Rates - Despite the rising incidence, thyroid cancer has a relatively low mortality rate, with both male and female death rates not ranking in the top ten for cancer-related deaths [3] - The five-year survival rate for thyroid cancer in China is 92.9%, which is lower than the 98%-99% survival rates in the United States [4] Recurrence and Management - The recurrence rate for thyroid cancer can reach 20% after ten years, with high-risk patients experiencing rates exceeding 30% [4] - Experts stress the importance of dynamic assessment and standardized follow-up care to mitigate recurrence risks [4][5] - Patients should undergo stratified risk assessments based on pathology, tumor size, and lymph node involvement to determine follow-up frequency and treatment strategies [5] Treatment and Follow-Up Protocols - The use of recombinant human thyroid-stimulating hormone (rh-TSH) for postoperative dynamic assessment is recommended to improve patient compliance and long-term survival rates [6] - Follow-up schedules should be tailored to individual patient needs, with initial assessments occurring one month post-surgery and subsequent evaluations based on treatment response [6][7] - Patients are advised against self-adjusting medication dosages and should maintain a balanced diet while managing stress levels to reduce recurrence risks [7] Awareness and Education - Establishing a Thyroid Cancer Prevention and Treatment Day is suggested to enhance public awareness and understanding of thyroid cancer management [7]